×
About 11,235 results

ALLMedicine™ Emphysema Center

Research & Reviews  3,598 results

Associations Between Morphological Phenotypes of COPD and Clinical Characteristics in S...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233490
International Journal of Chronic Obstructive Pulmonary Di... Suzuki Y, Kitaguchi Y et. al.

Jun 29th, 2022 - The associations between morphological phenotypes of COPD based on the chest computed tomography (CT) findings and clinical characteristics in surgically resected patients with COPD and concomitant lung cancer are unclear. The purpose of this stud...

Four Different Reasons of Subcutaneous Emphysema With or Without Pneumomediastinum and ...
https://doi.org/10.1097/SCS.0000000000008693
The Journal of Craniofacial Surgery; Choung HW, Choi YJ et. al.

Jun 29th, 2022 - In the present study, the authors report rare case series with subcutaneous emphysema with or without pneumomediastinum and pneumothorax after orthognathic and facial bone contouring surgery, compare their clinical and radiologic findings, and sug...

Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hyperte...
https://doi.org/10.1186/s12931-022-02081-y 10.1183/13993003.00610-2019 10.1017/gheg.2018.1 10.1016/j.chest.2021.02.012 10.1016/J.JACC.2009.04.012 10.1186/1465-9921-15-47 10.2174/138945011794751483 10.3389/fphys.2016.00457 10.21037/jtd.2018.07.63 10.1016/j.chest.2018.11.030 10.1016/S2213-2600(18)30327-8 10.3109/08958378.2012.715698 10.1016/j.chest.2021.08.040 10.3389/fcvm.2018.00151 10.1016/j.bcp.2009.04.029 10.2165/00003495-200969090-00002 10.1016/j.ebiom.2021.103479 10.1080/15412550902754252 10.1161/HYPERTENSIONAHA.114.03220 10.1371/journal.pone.0075415 10.29271/jcpsp.2020.06.568 10.1155/2016/3604842 10.1165/rcmb.2009-0220TR 10.1016/j.jphs.2015.08.008 10.1186/s12931-019-0975-4 10.1186/s12890-019-0915-6 10.1038/s41467-021-21961-3 10.1172/JCI136459 10.1038/s41467-019-12226-1 10.1093/cvr/cvs153 10.1183/13993003.01914-2018 10.1016/j.jaci.2016.05.011 10.1152/ajplung.00238.2014 10.3389/fimmu.2019.00085 10.3390/biom5031266 10.1371/journal.pone.0075415 10.1016/j.yjmcc.2005.06.012 10.1038/sj.emboj.7601539 10.1186/s12931-019-1133-8 10.1165/rcmb.2014-0045TR 10.1164/ajrccm.164.6.2010045 10.3389/fphar.2018.01426 10.1136/thorax.55.7.595 10.1183/09031936.00073506 10.1111/crj.13421 10.5604/17322693.1109219 10.7150/ijbs.4874 10.1161/CIRCRESAHA.108.182014 10.1007/s40265-019-01186-x 10.1164/ajrccm.183.1.139 10.1186/s12931-015-0262-y 10.1136/thx.54.4.372
Respiratory Research; Suraya R, Nagano T et. al.

Jun 28th, 2022 - Chronic obstructive pulmonary disease (COPD) is a health problem that results in death, commonly due to the development of pulmonary hypertension (PH). Here, by utilizing a mouse model of intratracheal elastase-induced emphysema that presents thre...

Inhaled Steroids, Sex and Emphysema Index - Clinical Parameters with Impact on the Effe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231414
International Journal of Chronic Obstructive Pulmonary Di... Polke M, Brugger J et. al.

Jun 28th, 2022 - Many patients with chronic obstructive lung disease suffer from emphysema. Valve implantation may be a reasonable method in patients presenting advanced emphysema and absent interlobar collateral ventilation (CV). However, other clinical parameter...

see more →

Guidelines  4 results

Expert Statement: Pneumothorax Associated with One-Way Valve Therapy for Emphysema: 202...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619763
Respiration; International Review of Thoracic Diseases; van Dijk M, Sue R et. al.

Jun 2nd, 2021 - For selected patients with advanced emphysema, bronchoscopic lung volume reduction with one-way valves can lead to clinically relevant improvements of airflow obstruction, hyperinflation, exercise capacity, and quality of life. The most common com...

Joint Statement of the German Respiratory Society and German Society of Thoracic Surger...
https://doi.org/10.1159/000511599
Respiration; International Review of Thoracic Diseases; Gesierich WJ, Darwiche K et. al.

Jan 8th, 2021 - Interventional treatment of emphysema offers a wide range of surgical and endoscopic options for patients with advanced disease. Multidisciplinary collaboration of pulmonology, thoracic surgery, and imaging disciplines in patient selection, therap...

Endobronchial Coils for Endoscopic Lung Volume Reduction: Best Practice Recommendations...
https://doi.org/10.1159/000490193
Respiration; International Review of Thoracic Diseases; Slebos DJ, Ten Hacken NH et. al.

Jul 11th, 2018 - Endobronchial coils are an additional treatment option for lung volume reduction in patients with severe emphysema. Patient selection should be focused on patients with severe emphysema on optimal medical therapy and with evidence of severe hyperi...

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373286
Canadian Respiratory Journal; Marciniuk DD, Hernandez P et. al.

Apr 27th, 2012 - Alpha-1 antitrypsin (A1AT) functions primarily to inhibit neutrophil elastase, and deficiency predisposes individuals to the development of chronic obstructive pulmonary disease (COPD). Severe A1AT deficiency occurs in one in 5000 to one in 5500 o...

see more →

Drugs  170 results see all →

Clinicaltrials.gov  379 results

NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
https://clinicaltrials.gov/ct2/show/NCT02327897

Jun 24th, 2022 - This study will be a prospective, longitudinal, observational, single-center, exploratory, natural history study to collect samples and data that will enable prospective explorations of the interaction between environmental exposures and disease p...

A Study of Belcesiran in Patients With A1ATD-Associated Liver Disease
https://clinicaltrials.gov/ct2/show/NCT04764448

Jun 21st, 2022 - A1ATD-associated liver disease is a progressive Alpha-1 Antitrypsin-Deficiency Associated Liver Disease condition resulting in liver fibrosis, cirrhosis, and hepatocellular carcinoma. The lack of functional A1AT in individuals with the PiZZ genoty...

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
https://clinicaltrials.gov/ct2/show/NCT04801108

Jun 13th, 2022 - We plan to approach all EBVs candidates that have < 95% lobar fissure completion. Once the patient agrees to participate and sign the consent, all the screening information collected as part of the standard of care will be extracted retrospectivel...

Study of COPD Subgroups and Biomarkers
https://clinicaltrials.gov/ct2/show/NCT01969344

Jun 10th, 2022 - SPIROMICS was initially funded through contracts from the NIH. That phase of SPIROMICS is now referred to as SPIROMICS I. SPIROMICS is now funded as a grant from the NIH. The current phase is referred to as SPIROMICS II. Brief summary of SPIROMICS...

Losartan Effects on Emphysema Progression
https://clinicaltrials.gov/ct2/show/NCT02696564

Jun 1st, 2022 - This is a trial designed to test if a treatment, losartan, may decrease the progression of Chronic Obstructive Pulmonary Disease (COPD). Losartan is an angiotensin receptor blocking agent, commonly used as an antihypertensive agent, which has been...

see more →

News  317 results

Pneumothorax, pneumomediastinum, and subcutaneous emphysema: The many faces of COVID-19 ARDS
https://www.mdedge.com/chestphysician/article/255343/critical-care/pneumothorax-pneumomediastinum-and-subcutaneous
Hafsa Abdulla, MD

Jun 13th, 2022 - I recall early in the pandemic being called to the bedside to examine an acutely decompensating patient with COVID-19. This was a 33-year-old, previously healthy woman, admitted to the medical ICU with hypoxemic respiratory failure requiring mecha.

Race-Based Spirometry May Lead to Missed Diagnoses
https://www.medscape.com/viewarticle/974063

May 16th, 2022 - SAN FRANCISCO — It may be time to move beyond relying largely on spirometry to distinguish between healthy and abnormal lung function in diverse populations. That conclusion comes from investigators who looked at patients with ostensibly normal sp...

Bronchoscopic lung reduction boosts survival in severe COPD
https://www.mdedge.com/chestphysician/article/254543/copd/bronchoscopic-lung-reduction-boosts-survival-severe-copd
Heidi Splete, MDedge News

May 11th, 2022 - Bronchoscopic lung volume reduction significantly increased survival in patients with severe chronic obstructive pulmonary disease, based on data from more than 1,400 individuals. Previous studies have shown that patients with severe chronic obstr.

Clinical Chest Images Power Up Survival Prediction in Lung Cancer
https://www.medscape.com/viewarticle/973280

May 2nd, 2022 - In patients with stage I lung cancer, adding noncancerous features from CT chest imaging predicts overall survival better than clinical characteristics alone, according to a paper published online in the American Journal of Roentgenology. Modeling...

FDA Approves Generic Symbicort for Asthma, COPD
https://www.medscape.com/viewarticle/970360

Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...

see more →

Patient Education  26 results see all →